{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T06:10:10Z","timestamp":1789884610178,"version":"4.0.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1143614"],"award-info":[{"award-number":["GNT1143614"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1180782"],"award-info":[{"award-number":["GNT1180782"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT2016283"],"award-info":[{"award-number":["GNT2016283"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1173892"],"award-info":[{"award-number":["GNT1173892"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1180782"],"award-info":[{"award-number":["GNT1180782"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Department of Education and Training | Australian Research Council","doi-asserted-by":"publisher","award":["DP200102903"],"award-info":[{"award-number":["DP200102903"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001171","name":"Cancer Institute NSW","doi-asserted-by":"publisher","award":["2018\/ECF001"],"award-info":[{"award-number":["2018\/ECF001"]}],"id":[{"id":"10.13039\/501100001171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001171","name":"Cancer Institute NSW","doi-asserted-by":"publisher","award":["ECF1299"],"award-info":[{"award-number":["ECF1299"]}],"id":[{"id":"10.13039\/501100001171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001184","name":"Cure Cancer Australia Foundation","doi-asserted-by":"publisher","award":["CCAF2023-Bond"],"award-info":[{"award-number":["CCAF2023-Bond"]}],"id":[{"id":"10.13039\/501100001184","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001081","name":"Hunter Medical Research Institute","doi-asserted-by":"publisher","award":["HMRI778"],"award-info":[{"award-number":["HMRI778"]}],"id":[{"id":"10.13039\/501100001081","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1038\/s41375-025-02693-5","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T15:42:38Z","timestamp":1752766958000},"page":"2275-2280","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Hypomethylating agents induce epigenetic and transcriptional heterogeneity with implications for acute myeloid leukemia cell self-renewal"],"prefix":"10.1038","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5967-0258","authenticated-orcid":false,"given":"Danielle R.","family":"Bond","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2149-3556","authenticated-orcid":false,"given":"Sean M.","family":"Burnard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumar","family":"Uddipto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kooper V.","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke M.","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiza","family":"Steffens Reinhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charley","family":"Lawlor-O\u2019Neill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellise A.","family":"Roper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Humphries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8953-3708","authenticated-orcid":false,"given":"Heather C.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul","family":"Mannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9063-5370","authenticated-orcid":false,"given":"Matthew D.","family":"Dun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5182-8535","authenticated-orcid":false,"given":"Charles E.","family":"de Bock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6047-1694","authenticated-orcid":false,"given":"Nikola A.","family":"Bowden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8069-090X","authenticated-orcid":false,"given":"Anoop K.","family":"Enjeti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7894-0137","authenticated-orcid":false,"given":"Nicole M.","family":"Verrills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2551-7618","authenticated-orcid":false,"given":"Carlos","family":"Riveros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim-Anh","family":"L\u00ea Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6482-0337","authenticated-orcid":false,"given":"Heather J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,17]]},"reference":[{"key":"2693_CR1","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1038\/s41375-021-01218-0","volume":"35","author":"J Stomper","year":"2021","unstructured":"Stomper J, Rotondo JC, Greve G, Lubbert M. Hypomethylating agents (HMA) for the treatment of acute myeloid leukemia and myelodysplastic syndromes: mechanisms of resistance and novel HMA-based therapies. Leukemia. 2021;35:1873\u201389.","journal-title":"Leukemia"},{"key":"2693_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26258-z","volume":"12","author":"J Diesch","year":"2021","unstructured":"Diesch J, Le Pannerer MM, Winkler R, Casquero R, Muhar M, van der Garde M, et al. Inhibition of CBP synergizes with the RNA-dependent mechanisms of Azacitidine by limiting protein synthesis. Nat Commun. 2021;12:6060.","journal-title":"Nat Commun"},{"key":"2693_CR3","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1038\/s41375-020-1003-x","volume":"35","author":"X Gu","year":"2021","unstructured":"Gu X, Tohme R, Tomlinson B, Sakre N, Hasipek M, Durkin L, et al. Decitabine- and 5-azacytidine resistance emerges from adaptive responses of the pyrimidine metabolism network. Leukemia. 2021;35:1023\u201336.","journal-title":"Leukemia"},{"key":"2693_CR4","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1158\/0008-5472.CAN-19-1696","volume":"80","author":"H Ohtani","year":"2020","unstructured":"Ohtani H, Orskov AD, Helbo AS, Gillberg L, Liu M, Zhou W, et al. Activation of a subset of evolutionarily young transposable elements and innate immunity are linked to clinical responses to 5-azacytidine. Cancer Res. 2020;80:2441\u201350.","journal-title":"Cancer Res"},{"key":"2693_CR5","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s42255-020-0174-0","volume":"2","author":"B Huang","year":"2020","unstructured":"Huang B, Song BL, Xu C. Cholesterol metabolism in cancer: mechanisms and therapeutic opportunities. Nat Metab. 2020;2:132\u201341.","journal-title":"Nat Metab"},{"key":"2693_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-020-00937-y","volume":"12","author":"H Takeshima","year":"2020","unstructured":"Takeshima H, Yoda Y, Wakabayashi M, Hattori N, Yamashita S, Ushijima T. Low-dose DNA demethylating therapy induces reprogramming of diverse cancer-related pathways at the single-cell level. Clin Epigenet. 2020;12:142.","journal-title":"Clin Epigenet"},{"key":"2693_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-09765-x","volume":"12","author":"KV Hunt","year":"2022","unstructured":"Hunt KV, Burnard SM, Roper EA, Bond DR, Dun MD, Verrills NM, et al. scTEM-seq: single-cell analysis of transposable element methylation to link global epigenetic heterogeneity with transcriptional programs. Sci Rep. 2022;12:5776.","journal-title":"Sci Rep"},{"key":"2693_CR8","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1158\/2159-8290.CD-19-0897","volume":"10","author":"S Li","year":"2020","unstructured":"Li S, Chen X, Wang J, Meydan C, Glass JL, Shih AH, et al. Somatic mutations drive specific, but reversible, epigenetic heterogeneity states in AML. Cancer Discov. 2020;10:1934\u201349.","journal-title":"Cancer Discov"},{"key":"2693_CR9","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1158\/2767-9764.CRC-23-0389","volume":"4","author":"I Campillo-Marcos","year":"2024","unstructured":"Campillo-Marcos I, Casado-Pelaez M, Davalos V, Ferrer G, Mata C, Mereu E, et al. Single-cell multiomics analysis of myelodysplastic syndromes and clinical response to hypomethylating therapy. Cancer Res Commun. 2024;4:365\u201377.","journal-title":"Cancer Res Commun"},{"key":"2693_CR10","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13046-025-03294-x","volume":"44","author":"MK Jakobsen","year":"2025","unstructured":"Jakobsen MK, Traynor S, Nielsen AY, Dahl C, Staehr M, Jakobsen ST, et al. Stochastic demethylation and redundant epigenetic suppressive mechanisms generate highly heterogeneous responses to pharmacological DNA methyltransferase inhibition. J Exp Clin Cancer Res. 2025;44:21.","journal-title":"J Exp Clin Cancer Res"},{"key":"2693_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113098","volume":"42","author":"T Yabushita","year":"2023","unstructured":"Yabushita T, Chinen T, Nishiyama A, Asada S, Shimura R, Isobe T, et al. Mitotic perturbation is a key mechanism of action of decitabine in myeloid tumor treatment. Cell Rep. 2023;42:113098.","journal-title":"Cell Rep"},{"key":"2693_CR12","doi-asserted-by":"publisher","first-page":"3838","DOI":"10.1182\/bloodadvances.2023009818","volume":"7","author":"A Afzal","year":"2023","unstructured":"Afzal A, Fiala MA, Jacoby MA, Walter MJ. Statin use in myelodysplastic syndromes is associated with a better survival and decreased progression to leukemia. Blood Adv. 2023;7:3838\u201341.","journal-title":"Blood Adv"},{"key":"2693_CR13","doi-asserted-by":"publisher","first-page":"5940","DOI":"10.1182\/blood-2023-188086","volume":"142","author":"EA Brem","year":"2023","unstructured":"Brem EA, O\u2019Brien SM, Becker PS, Jeyakumar D, Pinter-Brown LC, Kirk C, et al. A phase 1 study of adding pitavastatin to venetoclax-based therapy in AML and CLL\/SLL. Blood. 2023;142:5940.","journal-title":"Blood"},{"key":"2693_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101592","volume":"5","author":"HZ Guo","year":"2024","unstructured":"Guo HZ, Feng RX, Zhang YJ, Yu YH, Lu W, Liu JJ, et al. A CD36-dependent non-canonical lipid metabolism program promotes immune escape and resistance to hypomethylating agent therapy in AML. Cell Rep Med. 2024;5:101592.","journal-title":"Cell Rep Med"},{"key":"2693_CR15","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1158\/1535-7163.MCT-08-1196","volume":"8","author":"A Sassano","year":"2009","unstructured":"Sassano A, Lo Iacono M, Antico G, Jordan A, Uddin S, Calogero RA, et al. Regulation of leukemic cell differentiation and retinoid-induced gene expression by statins. Mol Cancer Ther. 2009;8:615\u201325.","journal-title":"Mol Cancer Ther"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02693-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02693-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02693-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T13:18:42Z","timestamp":1757251122000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02693-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,17]]},"references-count":15,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["2693"],"URL":"https:\/\/doi.org\/10.1038\/s41375-025-02693-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.01.30.577864","asserted-by":"object"}]},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,17]]},"assertion":[{"value":"10 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"AKE declares the following competing interests: advisory board and honoraria from AbbVie, Astellas, Gilead, Servier, Jazz, Otsuka\/Astex, and RACE Oncology; speaker fees from AbbVie, Otsuka\/Astex, Astellas and Jazz; Research Funding from RACE oncology and Otsuka\/Astex. NAB receives research funding from Merck KGaA and Bristol Myers Squibb.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All experimental procedures using animals were reviewed, approved, and performed according to the Animal Care and Ethics Committee of the University of Newcastle (approval number: A-2023-303), and with consideration of the ARRIVE guidelines (Supplementary Information).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}